Effects of annealing lyophilized and spray-lyophilized formulations of recombinant human interferon-gamma.

The purpose of this study was to examine the effects of adsorption of recombinant human interferon-gamma (rhIFN-gamma) on ice surfaces and subsequent drying during processing by spray-lyophilization and lyophilization. Ice/liquid interfacial areas were manipulated by the freezing method as well as by the addition of an annealing step during lyophilization; that is, rhIFN-gamma adsorption was modified by the addition of nonionic surfactants. rhIFN-gamma was lyophilized or spray-lyophilized at a concentration of 1 mg/mL in 5% sucrose, 5% hydroxyethyl starch (HES) +/- 0.03% polysorbate 20 in 140 mM KCl, and 10 mM potassium phosphate, pH 7.5. After the samples were frozen, half were annealed on the lyophilizer shelf. Recovery of soluble protein was measured at intermediate points during processing. On drying, the secondary structure of rhIFN-gamma was determined by second-derivative infrared (IR) spectroscopy, specific surface areas (SSAs) were measured, scanning electron micrographs (SEM) were taken, and dissolution times were recorded. Adsorption of rhIFN-gamma to ice/liquid interfaces alone was not responsible for aggregation. Rather, drying was necessary to cause aggregation in lyophilized sucrose formulations. Addition of an annealing step to the lyophilization cycle resulted in more native-like secondary protein structure in the dried solid, eliminated cracking of the dried cakes, and suppressed both the formation of air/liquid interfaces and rhIFN-gamma aggregation on reconstitution.

[1]  Kai Griebenow,et al.  Protein Spray-Freeze Drying. Effect of Atomization Conditions on Particle Size and Stability , 2000, Pharmaceutical Research.

[2]  Michael J. Pikal,et al.  Freeze‐Drying of Proteins. Process, Formulation, and Stability. , 1995 .

[3]  M. Manning,et al.  Quantitation of the area of overlap between second-derivative amide I infrared spectra to determine the structural similarity of a protein in different states. , 1996, Journal of pharmaceutical sciences.

[4]  B. Chang,et al.  Use of subambient thermal analysis to optimize protein lyophilization , 1992 .

[5]  A. Klibanov,et al.  Deterioration of lyophilized pharmaceutical proteins. , 1998, Biochemistry. Biokhimiia.

[6]  L. Berg.  pH changes in buffers and foods during freezing and subsequent storage , 1966 .

[7]  S J Prestrelski,et al.  Factors affecting short-term and long-term stabilities of proteins. , 2001, Advanced drug delivery reviews.

[8]  S E Ealick,et al.  Three-dimensional structure of recombinant human interferon-gamma. , 1991, Science.

[9]  B. Chang,et al.  Surface-induced denaturation of proteins during freezing and its inhibition by surfactants. , 1996, Journal of pharmaceutical sciences.

[10]  J. Beijnen,et al.  Pharmaceutical Development of (Investigational) Anticancer Agents for Parenteral Use-A Review , 1996 .

[11]  J. Carpenter,et al.  Annealing to optimize the primary drying rate, reduce freezing-induced drying rate heterogeneity, and determine T(g)' in pharmaceutical lyophilization. , 2001, Journal of pharmaceutical sciences.

[12]  J. May,et al.  Determination of residual moisture in freeze-dried viral vaccines: Karl Fischer gravimetric and thermogravimetric methodologies. , 1982, Journal of biological standardization.

[13]  M. Hageman,et al.  Effects of buffer composition and processing conditions on aggregation of bovine IgG during freeze-drying. , 1999, Journal of pharmaceutical sciences.

[14]  M. Pikal,et al.  Intravial distribution of moisture during the secondary drying stage of freeze drying. , 1997, PDA journal of pharmaceutical science and technology.

[15]  J L Cleland,et al.  The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation. , 1993, Critical reviews in therapeutic drug carrier systems.

[16]  F. Franks.  The Properties of Aqueous Solutions at Subzero Temperatures , 1982 .

[17]  E. Gabellieri,et al.  Proteins in frozen solutions: evidence of ice-induced partial unfolding. , 1996, Biophysical journal.

[18]  M. Manning,et al.  Infrared and circular dichroism spectroscopic characterization of structural differences between beta-lactoglobulin A and B. , 1996, Biochemistry.

[19]  H. Susi,et al.  Examination of the secondary structure of proteins by deconvolved FTIR spectra , 1986, Biopolymers.

[20]  Chung C. Hsu,et al.  Surface Denaturation at Solid-Void Interface—A Possible Pathway by Which Opalescent Participates Form During the Storage of Lyophilized Tissue-Type Plasminogen Activator at High Temperatures , 2004, Pharmaceutical Research.

[21]  E. Teller,et al.  ADSORPTION OF GASES IN MULTIMOLECULAR LAYERS , 1938 .

[22]  Michael J. Pikal,et al.  Rational Design of Stable Lyophilized Protein Formulations: Some Practical Advice , 1997, Pharmaceutical Research.

[23]  J. Carpenter,et al.  The ice nucleation temperature determines the primary drying rate of lyophilization for samples frozen on a temperature-controlled shelf. , 2001, Journal of pharmaceutical sciences.

[24]  M. Pikal,et al.  Effect of Initial Buffer Composition on pH Changes During Far-From-Equilibrium Freezing of Sodium Phosphate Buffer Solutions , 2004, Pharmaceutical Research.

[25]  Steven L. Nail,et al.  Measurement of Glass Transition Temperatures of Freeze-Concentrated Solutes by Differential Scanning Calorimetry , 2004, Pharmaceutical Research.

[26]  M. Manning,et al.  Aggregation of recombinant human interferon gamma: kinetics and structural transitions. , 1998, Journal of pharmaceutical sciences.

[27]  M. Manning,et al.  Spectroscopic study of secondary structure and thermal denaturation of recombinant human factor XIII in aqueous solution. , 1997, Archives of biochemistry and biophysics.

[28]  Theodore W Randolph,et al.  Surface adsorption of recombinant human interferon-gamma in lyophilized and spray-lyophilized formulations. , 2002, Journal of pharmaceutical sciences.

[29]  S J Prestrelski,et al.  Biopharmaceutical powders: particle formation and formulation considerations. , 2000, Current pharmaceutical biotechnology.

[30]  J. Carpenter,et al.  A new mechanism for decreasing aggregation of recombinant human interferon-gamma by a surfactant: slowed dissolution of lyophilized formulations in a solution containing 0.03% polysorbate 20. , 2002, Journal of pharmaceutical sciences.

[31]  W. Caughey,et al.  Infrared methods for study of hemoglobin reactions and structures. , 1994, Methods in enzymology.

[32]  A. I. Liapis,et al.  ESTIMATION OF THE EFFECT OF PRODUCT SHRINKAGE ON THE DRYING TIMES, HEAT INPUT AND CONDENSER LOAD OF THE PRIMARY AND SECONDARY DRYING STAGES OF THE LYOPHILIZATION PROCESS IN VIALS , 1999 .